Pharmaceuticals as a market for "lemons": Theory and practice.

Social Science & Medicine
Donald W Light, Joel R Lexchin


Drawing on economic theory and institutional analysis, this paper reframes Akerlof's theory of how a market for lemons operates and argues that each of the many markets for lemons must be studied empirically to document how different stakeholders cope with the problems of information asymmetry, secrecy, and power. Such markets are a new field for sociological analysis. To illustrate, the paper characterizes pharmaceuticals as a multi-tier market of information asymmetry in which actors in each tier have substantial control over how much they disclose about hidden risks of harm. Such a market rewards the production and sale of "lemons." Current incentives and institutional practices reward developing a large number of barely therapeutically innovative drugs and ignoring their often hidden or understated harmful side effects. They reward designing and executing substandard, biased trials that mislead the FDA and regulators abroad to approve new drugs without clear evidence of their degree of harm. Approved drugs are likely to be "lemons" but promoted as "safe and effective." The result is substantial hospitalizations and deaths from adverse drug reactions. A "risk proliferation syndrome" of institutional practices maximizes sales...Continue Reading


Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Jul 25, 2000·JAMA : the Journal of the American Medical Association·B Starfield
Nov 13, 2002·Pharmacoepidemiology and Drug Safety·James CrossCarl Peck
Jan 15, 2003·European Journal of Clinical Pharmacology·Francesco PignattiPatrick Le Courtois
Mar 3, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Wayne Kondro, Barbara Sibbald
Nov 24, 2004·Journal of Health Economics·Mary K Olson
Mar 5, 2005·The American Journal of Medicine·Jerry H GurwitzDavid W Bates
Sep 6, 2005·BMJ : British Medical Journal·Steven G MorganCharlyn D Black
Aug 16, 2006·Annals of Internal Medicine·Michael A SteinmanC Seth Landefeld
Jan 24, 2007·Lancet·J Abramson, J M Wright
Apr 26, 2007·PLoS Medicine·Michael A SteinmanLisa A Bero
Apr 26, 2007·PLoS Medicine·Adriane Fugh-Berman, Shahram Ahari
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Sep 12, 2007·Archives of Internal Medicine·Thomas J MooreCurt D Furberg
Jan 18, 2008·The New England Journal of Medicine·Erick H TurnerRobert Rosenthal
Feb 29, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F TrottaG Tafuri
Mar 28, 2008·The New England Journal of Medicine·Daniel CarpenterJerry Avorn
Apr 17, 2008·JAMA : the Journal of the American Medical Association·Joseph S RossHarlan M Krumholz
Aug 20, 2008·Annals of Internal Medicine·Kevin P HillHarlan M Krumholz
Sep 3, 2008·Sociology of Health & Illness·Peter Conrad, Valerie Leiter
Jan 9, 2009·The New England Journal of Medicine·C Seth Landefeld, Michael A Steinman
Apr 28, 2009·Perspectives in Biology and Medicine·Linsey McGoey
Aug 29, 2009·The Hastings Center Report·Kalman Applbaum
Oct 28, 2009·Archives of Internal Medicine·Isabelle PitrouPhilippe Ravaud
Dec 19, 2009·Journal of Health Politics, Policy and Law·John Abraham
May 11, 2010·Journal of the American Board of Family Medicine : JABFM·James W MoldLaine H McCarthy
Sep 15, 2010·PLoS Medicine·Adriane J Fugh-Berman
Jan 15, 2011·American Journal of Public Health·Howard Brody, Donald W Light
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Aaron S KesselheimJerry Avorn
Apr 18, 2012·Archives of Internal Medicine·Tewodros EgualeRobyn Tamblyn
Oct 18, 2013·Orphanet Journal of Rare Diseases·Eline PicavetSteven Simoens
Feb 13, 2018·Psychiatria polska·Jay D AmsterdamJon N Jureidini
Jan 24, 2020·BMJ : British Medical Journal·Alice FabbriBarbara Mintzes
Mar 23, 2020·Lancet·Huseyin NaciAndrea Cipriani
Apr 28, 2020·JAMA Internal Medicine·Emerson Y ChenVinay Prasad

❮ Previous
Next ❯


Jul 15, 2021·Journal of Pharmaceutical Policy and Practice·Agnes Vitry, Barbara Mintzes

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Internal Medicine
Michael S Lauer
Journal of the California Dental Association
David W Chambers
Atencion primaria
José Luis Turabián Fernández, Benjamín Pérez Franco
Journal of the Pediatric Infectious Diseases Society
Stanley A Plotkin
© 2021 Meta ULC. All rights reserved